BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment. BIOLASE’s products are focused on better enabling clinicians to repair and restore patient’s dental conditions while reducing the pain, fear, and anxiety generally associated with dentistry. BIOLASE is committed to elevating the standard of care in dentistry, while enabling clinicians to achieve better business returns.

Company Growth (employees)
Type
Public
HQ
Irvine, US
Founded
1987
Size (employees)
225 (est)+13%
Biolase was founded in 1987 and is headquartered in Irvine, US

Key People at Biolase

Jeffrey Nugent

Jeffrey Nugent

President and Chief Executive Officer
Dmitri Boutoussov

Dmitri Boutoussov

CTO
Frederick D. Furry

Frederick D. Furry

Chief Financial Officer
William E. Brown

William E. Brown

VP, Business Development

Biolase Office Locations

Biolase has offices in Irvine, Miami, Denver, Seattle and in 14 other locations
Irvine, US (HQ)
4 Cromwell
Show all (18)

Biolase Data and Metrics

Biolase Financial Metrics

Biolase's revenue was reported to be $10.9 m in Q1, 2017
USD

Revenue (Q1, 2017)

10.9 m

Gross profit (Q1, 2017)

4 m

Gross profit margin (Q1, 2017), %

36%

Net income (Q1, 2017)

(4.1 m)

EBIT (Q1, 2017)

(4.1 m)

Market capitalization (22-Aug-2017)

38.6 m

Cash (31-Mar-2017)

3.6 m
Biolase's current market capitalization is $38.6 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

56.4 m47.7 m48.5 m51.8 m

Revenue growth, %

(16%)2%7%

Cost of goods sold

34.9 m29.5 m32.5 m31.5 m

Gross profit

21.5 m18.2 m16 m20.3 m

Gross profit Margin, %

38%38%33%39%

EBIT

(11 m)(17.9 m)(19.9 m)(15 m)

EBIT margin, %

(19%)(38%)(41%)(29%)

Interest income

74 k74 k

Net Income

(11.5 m)(18.9 m)(20.3 m)(15.4 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

10.2 m12.7 m10.9 m11.9 m11.2 m11 m13.8 m13.2 m10.9 m

Cost of goods sold

6.5 m7.3 m7.6 m8.2 m7.9 m7.4 m8.2 m7.6 m6.9 m

Gross profit

3.7 m5.4 m3.2 m3.7 m3.4 m3.6 m5.7 m5.6 m4 m

Gross profit Margin, %

37%42%30%31%30%33%41%42%36%

Sales and marketing expense

3.6 m3.9 m4.8 m4.7 m4 m3.8 m4.5 m4.3 m4.2 m

General and administrative expense

5.3 m3.5 m2.6 m3.9 m2.9 m2.3 m2.7 m2.8 m2.4 m

Operating expense total

8.9 m7.3 m7.3 m8.7 m6.9 m6.1 m7.1 m7 m6.6 m

EBIT

(6.2 m)(3.3 m)(5.3 m)(7 m)(5.4 m)(4.3 m)(3.4 m)(3.1 m)(4.1 m)

EBIT margin, %

(61%)(26%)(48%)(59%)(48%)(39%)(25%)(24%)(37%)

Interest expense

185 k37 k230 k23 k21 k17 k

Interest income

23 k21 k17 k

Income tax expense

29 k28 k47 k36 k44 k40 k37 k40 k40 k

Net Income

(11.3 m)(14.8 m)(5.4 m)(12.5 m)(17.8 m)(4.3 m)(7.8 m)(10.9 m)(4.1 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

1.4 m31.6 m11.7 m8.9 m

Inventories

1.9 m1.7 m1.4 m13.5 m

Current Assets

25.9 m54.8 m34.8 m34 m

PP&E

1.8 m1.3 m3.7 m4.5 m

Goodwill

2.9 m2.9 m2.9 m2.9 m

Total Assets

31 m59.4 m42.3 m41.9 m

Accounts Payable

8.6 m8.4 m6 m9.1 m

Current Liabilities

21.9 m16.2 m15.1 m18 m

Total Liabilities

19.9 m

Additional Paid-in Capital

148.9 m185.2 m188.6 m201.2 m

Retained Earnings

(123.8 m)(142.7 m)(163 m)(178.3 m)

Total Equity

42.1 m24.9 m22.1 m

Financial Leverage

1.4 x1.7 x1.9 x
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

2.1 m2.8 m19.9 m15.2 m6.6 m4.9 m12.7 m3.6 m

Inventories

11.9 m11.8 m13.7 m14.1 m12.6 m11.3 m13.5 m14.7 m

Current Assets

21.4 m25.1 m45.2 m40.3 m31.1 m28.5 m37.3 m29.3 m

PP&E

1.6 m1.5 m2.4 m3.1 m3.8 m4 m3.9 m4.5 m

Goodwill

2.9 m2.9 m2.9 m2.9 m2.9 m2.9 m2.9 m2.9 m

Total Assets

26.4 m29.9 m51.3 m47.1 m38.4 m36 m44.6 m37 m

Accounts Payable

10 m9.5 m8.8 m9.3 m7 m6.9 m7.9 m9.2 m

Current Liabilities

22.6 m17.8 m17.9 m18.3 m14.5 m15 m16.4 m17.1 m

Additional Paid-in Capital

154.6 m150.1 m186.9 m187.5 m189.5 m190.4 m200.6 m201.6 m

Retained Earnings

(135.1 m)(138.6 m)(155.2 m)(160.5 m)(167.2 m)(170.8 m)(173.9 m)(182.4 m)

Total Equity

2.9 m11.1 m31.1 m26.3 m21.6 m19 m26.1 m18.4 m

Financial Leverage

9.1 x2.7 x1.7 x1.8 x1.8 x1.9 x1.7 x2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(11.5 m)(18.9 m)(20.3 m)(15.4 m)

Depreciation and Amortization

601 k696 k880 k1 m

Accounts Receivable

264 k826 k(52 k)(644 k)

Inventories

56 k(21 k)(65 k)(2 m)

Cash From Operating Activities

(1.1 m)

Purchases of PP&E

(198 k)(1.4 m)

Cash From Investing Activities

(685 k)(197 k)(1.8 m)(1.4 m)

Interest Paid

220 k148 k4 k4 k

Income Taxes Paid

47 k52 k57 k76 k
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(11.3 m)(14.8 m)(5.4 m)(12.5 m)(17.8 m)(4.3 m)(7.8 m)(10.9 m)(4.1 m)

Depreciation and Amortization

352 k529 k158 k324 k589 k212 k488 k776 k290 k

Accounts Receivable

3.8 m1.1 m(860 k)(1 m)(500 k)(1.1 m)(2 m)(863 k)564 k

Inventories

(733 k)(682 k)(664 k)(1.2 m)(1.6 m)(1 k)908 k(1.4 m)(1.4 m)

Purchases of PP&E

(343 k)(502 k)(1.1 m)(208 k)

Cash From Investing Activities

(122 k)(193 k)(228 k)(433 k)(1.2 m)(343 k)(502 k)(1.1 m)(208 k)

Cash From Financing Activities

(43 k)

Interest Paid

101 k143 k67 k101 k2 k1 k2 k3 k1 k

Income Taxes Paid

34 k45 k37 k44 k53 k33 k48 k66 k7 k
USDY, 2017

Revenue/Employee

51.2 k

Financial Leverage

2 x

Biolase Market Value History

Biolase Job Categories

Traffic Overview of Biolase

Biolase Online and Social Media Presence

Biolase Company Life and Culture

You may also be interested in